Watch for Mix-Ups With the New COPD Three-Drug Inhaler Combo Trelegy Ellipta

January 2018

Trelegy Ellipta will be the first “three-in-one” inhaler for COPD....

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Shortages Use Creative Strategies to Conserve IV Fluids During Shortages
Infectious Diseases Help Reduce Empiric Broad-Spectrum Antibiotic Use for Skin Infections
Neurology & Pain Weigh the Pros and Cons of Using IV Lidocaine for Pain
Influenza Stick With Oseltamivir to Treat Hospitalized Flu Patients
New Drugs Watch for Mix-Ups With the New COPD Three-Drug Inhaler Combo Trelegy Ellipta
Substance Use Disorder Know How to Treat Acute Pain in Patients Taking Meds for Opioid Dependence
Hypertension Expect More Patients to Be on Antihypertensives at Home
Hypothyroidism Discourage Routinely Checking TSH Levels in Hospitalized Patients
Diabetes Meds Ensure Safe Use of Sulfonylureas for Type 2 Diabetes
Med Safety Educate Discharge Patients About Meds Linked to Driving Impairment
New Drugs Watch for Mix-Ups With the New COPD Three-Drug Inhaler Combo Trelegy Ellipta